Roger Song
Stock Analyst at Jefferies
(0.94)
# 3,047
Out of 4,479 analysts
20
Total ratings
31.25%
Success rate
-15.25%
Average return
Main Sectors:
Top Industries:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CTMX CytomX Therapeutics | Upgrades: Buy | $2.5 → $8 | $1.32 | +506.06% | 3 | May 6, 2024 | |
| NUVL Nuvalent | Initiates: Buy | $97 | $73.00 | +32.88% | 1 | Apr 17, 2024 | |
| TRML Tourmaline Bio | Maintains: Buy | $41 → $72 | $12.55 | +473.71% | 2 | Mar 20, 2024 | |
| VKTX Viking Therapeutics | Initiates: Buy | $110 | $51.54 | +113.43% | 1 | Mar 7, 2024 | |
| NKTR Nektar Therapeutics | Maintains: Hold | $0.5 → $1 | $1.17 | -14.53% | 4 | Mar 6, 2024 | |
| IGMS IGM Biosciences | Assumes: Buy | $61 → $55 | $6.40 | +759.38% | 1 | Nov 9, 2022 | |
| ALT Altimmune | Maintains: Buy | $30 → $35 | $6.74 | +419.29% | 1 | Aug 31, 2022 | |
| PRLD Prelude Therapeutics | Initiates: Buy | $9 | $3.73 | +141.29% | 1 | Jul 29, 2022 | |
| KURA Kura Oncology | Initiates: Buy | $35 | $20.58 | +70.07% | 1 | Feb 15, 2022 | |
| AADI Aadi Bioscience | Initiates: Buy | $675 | $1.32 | +51,036.36% | 1 | Jan 11, 2022 | |
| CRVS Corvus Pharmaceuticals | Initiates: Buy | n/a | $1.78 | - | 1 | Dec 1, 2021 | |
| GLYC GlycoMimetics | Upgrades: Buy | n/a | $0.27 | - | 1 | Nov 12, 2021 | |
| MTEM Molecular Templates | Initiates: Buy | n/a | $1.16 | - | 1 | Sep 8, 2020 | |
| STRO Sutro Biopharma | Initiates: Buy | n/a | $2.96 | - | 1 | Sep 2, 2020 |
CytomX Therapeutics
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $1.32
Upside: +506.06%
Nuvalent
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $73.00
Upside: +32.88%
Tourmaline Bio
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $12.55
Upside: +473.71%
Viking Therapeutics
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $51.54
Upside: +113.43%
Nektar Therapeutics
Mar 6, 2024
Maintains: Hold
Price Target: $0.5 → $1
Current: $1.17
Upside: -14.53%
IGM Biosciences
Nov 9, 2022
Assumes: Buy
Price Target: $61 → $55
Current: $6.40
Upside: +759.38%
Altimmune
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $6.74
Upside: +419.29%
Prelude Therapeutics
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $3.73
Upside: +141.29%
Kura Oncology
Feb 15, 2022
Initiates: Buy
Price Target: $35
Current: $20.58
Upside: +70.07%
Aadi Bioscience
Jan 11, 2022
Initiates: Buy
Price Target: $675
Current: $1.32
Upside: +51,036.36%
Corvus Pharmaceuticals
Dec 1, 2021
Initiates: Buy
Price Target: n/a
Current: $1.78
Upside: -
GlycoMimetics
Nov 12, 2021
Upgrades: Buy
Price Target: n/a
Current: $0.27
Upside: -
Molecular Templates
Sep 8, 2020
Initiates: Buy
Price Target: n/a
Current: $1.16
Upside: -
Sutro Biopharma
Sep 2, 2020
Initiates: Buy
Price Target: n/a
Current: $2.96
Upside: -